← Back to headlines
Candel Therapeutics Reports Q4 GAAP EPS of -$0.54
Candel Therapeutics announced its GAAP EPS for the fourth quarter was -$0.54.
12 Mar, 19:02 — 12 Mar, 19:02
Sources
Showing 1 of 1 sources
Related Stories
Gold continues lackluster showing since start of Iran war while oil keeps climbing
20m ago
Wall Street Traders Hunt for Bottom as War Turmoil Continues - Bloomberg.com
44m ago
Greek Economy Growth Forecast Tied to Middle East Conflict
47m ago
Germany Fails to Sell Full Volume of Bonds Amid Investor Caution
47m ago